Latest Breaking News On - Day one biopharmaceuticals - Page 11 : comparemela.com

Brokers Offer Predictions for Day One Biopharmaceuticals, Inc s Q1 2025 Earnings (NASDAQ:DAWN)

Brokers Offer Predictions for Day One Biopharmaceuticals, Inc s Q1 2025 Earnings (NASDAQ:DAWN)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesJeremy benderAdam dubowDay one biopharmaceuticals incNeedham companyDay one biopharmaceuticals company profileSecurities exchange commissionGoldman sachs groupDay one biopharmaceuticalsFree reportDay one biopharmaceuticalOne biopharmaceuticalsDay oneExchange commissionGeneral counsel adam dubowState teachers retirement system

Day One Biopharmaceuticals (NASDAQ:DAWN) Stock Rating Reaffirmed by Oppenheimer

Day One Biopharmaceuticals (NASDAQ:DAWN – Get Free Report)‘s stock had its “market perform” rating restated by equities researchers at Oppenheimer in a report released on Tuesday, Benzinga reports. Several other research analysts have also issued reports on DAWN. Needham & Company LLC reaffirmed a “buy” rating and set a $34.00 target price on shares of […]

United statesAdam dubowJeremy benderSecurities exchange commissionNeedham companyDay one biopharmaceuticals company profileDay one biopharmaceuticals incDay one biopharmaceuticalsGet free reportOne biopharmaceuticalsExchange commissionGeneral counsel adam dubowDay oneState teachers retirement systemCapital managementState retirement system

The Goldman Sachs Group Trims Day One Biopharmaceuticals (NASDAQ:DAWN) Target Price to $44 00

The Goldman Sachs Group Trims Day One Biopharmaceuticals (NASDAQ:DAWN) Target Price to $44 00
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesJeremy benderGoldman sachs groupYork mellon corpMetlife investment managementDay one biopharmaceuticals incBlackrock incNeedham companySecurities exchange commissionAmerican international group incDay one biopharmaceuticalsGet free reportOne biopharmaceuticalsDay oneExchange commissionNew york mellon corp

Day One Biopharmaceuticals (NASDAQ:DAWN) Trading 10 8% Higher

Day One Biopharmaceuticals (NASDAQ:DAWN) Trading 10 8% Higher
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesJeremy benderNeedham companyMetlife investment managementGoldman sachs groupYork mellon corpBlackrock incAmerican international group incDay one biopharmaceuticals incDay one biopharmaceuticalsGet free reportDay oneNew york mellon corpLife investment managementAmerican international groupInternational group

Day One Biopharmaceuticals (NASDAQ:DAWN) Trading Up 10 8%

Day One Biopharmaceuticals (NASDAQ:DAWN) Trading Up 10 8%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Jeremy benderAdam dubowQuest partnersAmeritas investment partners incNeedham companyLife insurance coDay one biopharmaceuticals incSecurities exchange commissionGoldman sachs groupChina universal asset management coDay one biopharmaceuticalsGet free reportDay oneExchange commissionGeneral counsel adam dubowUniversal asset management